Ionis Pharmaceuticals IONS Repayments Of Secured Debt
Repayments Of Secured Debt at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RepaymentsOfSecuredDebt.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's repayments of secured debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's repayments of secured debt?
- Ionis Pharmaceuticals (IONS) reported repayments of secured debt of $44K in Q1 2026.
- How has Ionis Pharmaceuticals's repayments of secured debt changed year-over-year?
- Ionis Pharmaceuticals's repayments of secured debt increased by 4.8% year-over-year, from $42K to $44K.
- What is the long-term trend for Ionis Pharmaceuticals's repayments of secured debt?
- Over 3 years (2022 to 2025), Ionis Pharmaceuticals's repayments of secured debt has grown at a -84.9% compound annual growth rate (CAGR), from $50.69M to $175K.
- What does repayments of secured debt mean?
- Cash used to pay off debt that is backed by collateral.
- How do you interpret repayments of secured debt?
- Consistent repayment signals financial health and deleveraging, while zero or low repayment may indicate a preference for maintaining liquidity.
- How does repayments of secured debt compare across companies?
- Standard debt service metric used to assess balance sheet management.